METHOD FOR SURGICAL TREATMENT OF RESISTANT DIABETIC MACULAR EDEMA WITHOUT THE PRESENCE OF AN EPIRETINAL MEMBRANE Russian patent published in 2022 - IPC A61F9/07 A61K39/395 A61P27/02 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely ophthalmic surgery. First, a three-port closed vitrectomy is performed with the removal of the posterior hyaloid membrane. After that, the inner boundary membrane (IBM) in the temporal parafoveolar region is stained with a dye for IBM. Next, vitreal tweezers by the method for membranorex is the removal of a round-shaped area of the IBM with a diameter of 1.5-2.0 mm is performed, which does not capture the foveola and is located more temporally than the latter at an equal distance from the upper and lower temporal vascular arcades, so that the nasal edge of the IBM removal zone passes along the temporal edge of the foveola. The intervention is completed with intravitreal administration of aflibercept or ranibizumab.

EFFECT: method provides drainage of the edema zone into the vitreal cavity, improves the penetration of the drug to the retina, provides a long-term stable effect of treatment, while maintaining intact the foveolar region and the area of the papillomacular bundle, which prevents the occurrence of blindspots in the center of the field of vision.

1 cl, 1 ex, 6 dwg